Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Caenorhabditis elegans ADAR editing and the ERI-6/7/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons
2020 StandoutNobel
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
1994
Hallmarks of Cancer: The Next Generation
2011 Standout
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
mTOR Signaling in Growth Control and Disease
2012 Standout
Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma
1999
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
2003 Standout
Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer
1994
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
1995
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
Phylogeny of the Serpin Superfamily: Implications of Patterns of Amino Acid Conservation for Structure and Function
2000
Vascular targeting—a new approach to the therapy of solid tumors
1994
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
1990
3 The Medicinal Chemistry of the Azido Group
1994
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.
1989
Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinomain situ of the breast
1999
Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
1995
The microenvironment of the tumour–host interface
2001 StandoutNature
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
1995
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
1998
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival
1994
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
The role of vascular endothelial growth factor in pathological angiogenesis
1995
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Cystic fibrosis: molecular biology and therapeutic implications
1992 StandoutScience
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
1998
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Treatment of Breast Cancer
1998
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
1995
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Signal Transduction Pathways Mediated by PECAM-1
2003
An Animal Model for Cystic Fibrosis Made by Gene Targeting
1992 StandoutScienceNobel
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
1989 StandoutScience
Specific Targeting of Tumor Angiogenesis by RGD-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 1.5-T Magnetic Resonance Scanner
2007
Life with Oxygen
2007 StandoutScienceNobel
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
2000
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment
2000
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
The Biology of Vascular Endothelial Growth Factor
1997 Standout
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Estrogen and Angiogenesis
2001
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
1998
Mobilization of LINE-1 retrotransposons is restricted by Tex19.1 in mouse embryonic stem cells
2017
Identification of the Cystic Fibrosis Gene: Genetic Analysis
1989 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
PECAM-1/CD31 Trans-homophilic Binding at the Intercellular Junctions Is Independent of Its Cytoplasmic Domain; Evidence for Heterophilic Interaction with Integrin αvβ3 in Cis
2000
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
1993
Genetic Dissection of Complex Traits
1994 StandoutScience
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
1990 StandoutScience
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
1989 StandoutScience
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
1994
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
1989
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
1993
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Angiogenesis in Endocrine Tumors
2003
Geometric Control of Cell Life and Death
1997 StandoutScience
The Structure of Haplotype Blocks in the Human Genome
2002 StandoutScience
Surface molecular recognition
2001 StandoutNobel
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of N Stuart being referenced
A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES) ? a new dihydrofolate reductase inhibitor
1989
Angiogenesis in Breast Cancer
1993
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer
1996
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
1992
Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites
1993
Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes
2012
Genealogical analysis of cystic fibrosis families and chromosome 7q RFLP haplotypes in the Hutterite Brethren.
1989
Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.
1987